Alternatives to Prolia If You Can't Fill Your Prescription

Prolia (denosumab) is an effective treatment for osteoporosis, but not every patient can access it on time — or at all. Insurance denials, biosimilar transitions, and scheduling barriers can delay treatment. If you're in that situation, you're not without options. Here's a comprehensive look at FDA-approved alternatives to Prolia for osteoporosis, and what each one means for your bones.

Important Warning Before Switching: Do Not Stop Prolia Without a Plan

If you are currently taking Prolia, do NOT simply stop without transitioning to another antiresorptive medication. Stopping denosumab abruptly causes a rapid rebound in bone resorption that can dramatically increase your fracture risk — especially vertebral (spinal) fractures. Multiple fractures have been reported in patients who stopped Prolia cold. Always work with your provider to create a transition plan.

Option 1: Prolia Biosimilars (Easiest Transition)

Before switching drug classes, check if a Prolia biosimilar is available. Nine FDA-approved biosimilars exist as of 2026: Jubbonti, Bomyntra, Enoby, Osvyrti, Ponlimsi, Stoboclo, Boncresa, Aukelso, and Bildyos. They contain the same active ingredient (denosumab), work identically, and may be easier to source or covered preferentially by your insurance. If brand Prolia isn't available, ask specifically about these.

Option 2: Bisphosphonates — The First-Line Standard

Bisphosphonates are the most widely used osteoporosis medications and are often the recommended transition agent after stopping Prolia. They "bank" in bone tissue for years, providing lasting protection even when treatment is paused. Common options include:

• Alendronate (Fosamax): A weekly oral pill, widely available in generic form for as little as $4–$15 per month. Effective for reducing vertebral, hip, and non-vertebral fracture risk.
• Risedronate (Actonel): Available weekly or monthly; also generic and affordable.
• Zoledronic acid (Reclast): Given as a once-yearly intravenous infusion. Excellent for patients who can't tolerate oral bisphosphonates or have GI issues.

If you are stopping Prolia, your doctor will likely recommend transitioning directly to a bisphosphonate — typically zoledronic acid about 6 months after your last Prolia dose — to prevent the rebound fracture risk.

Option 3: Romosozumab (Evenity) — For High-Fracture-Risk Patients

Romosozumab (Evenity) is a monthly injection that both builds bone and reduces bone breakdown. It's approved for postmenopausal women with severe osteoporosis at very high fracture risk. However, it is limited to 12 monthly doses and is contraindicated in patients who have had a recent heart attack or stroke. It is typically followed by bisphosphonates or denosumab to preserve gains.

Option 4: Teriparatide (Forteo) and Abaloparatide (Tymlos)

Teriparatide (Forteo) and abaloparatide (Tymlos) are anabolic agents — they actually build new bone rather than just slowing bone loss. Both require daily subcutaneous injections and are generally reserved for patients with severe osteoporosis or very high fracture risk who have failed or cannot tolerate antiresorptive drugs. They are limited to 2 years of use and must be followed by antiresorptive therapy.

Option 5: Raloxifene (Evista) — For Spinal Fracture Prevention

Raloxifene is a selective estrogen receptor modulator (SERM) that reduces the risk of vertebral fractures in postmenopausal women. It is taken as a daily oral pill but is less effective than bisphosphonates for hip fracture prevention. It also increases the risk of blood clots and is generally not recommended as a first alternative to Prolia.

How to Talk to Your Doctor About Switching

When speaking with your provider, ask these questions:

1. "Is a denosumab biosimilar available as an alternative to brand Prolia?"
2. "If I need to stop Prolia, what transition medication do you recommend and when should I start it?"
3. "Would a bisphosphonate be appropriate given my fracture history and kidney function?"
4. "Am I a candidate for Evenity given my cardiovascular history?"

Also see: Why Is Prolia So Hard to Find? [Explained for 2026] for context on why supply issues occur.

If you need help locating Prolia or an approved biosimilar near you, medfinder can help you find the right dispensing provider quickly.